Indeed, c-Jun expression is affected by N-methyl-D-aspartate (NMDA) receptor antagonists such as MK-801 (Gerlach et al., 2002) mimicking a preclinical model of schizophrenia. The gene discussed is JUN; the disease is schizophrenia.